Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)
CUSIP: 45782T105
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 27,969,231
- Total 13F shares
- 1,305,763
- Share change
- +465,591
- Total reported value
- $15,492,692
- Price per share
- $11.88
- Number of holders
- 32
- Value change
- +$5,444,483
- Number of buys
- 24
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45782T105:
Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.9%
|
252,931
|
$4,356,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.78%
|
217,568
|
$3,747,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.34%
|
96,048
|
$1,654,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.22%
|
60,758
|
$1,323,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.2%
|
56,974
|
$981,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
33,655
|
$579,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
23,161
|
$399,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.08%
|
21,243
|
$366,000 | — | 31 Dec 2020 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.06%
|
18,167
|
$313,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
13,534
|
$233,000 | — | 31 Dec 2020 | |
| Diametric Capital, LP |
13F
|
Company |
0.04%
|
12,470
|
$215,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
12,374
|
$213,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
11,052
|
$190,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
6,000
|
$103,000 | — | 31 Dec 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.02%
|
4,400
|
$75,000 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,813
|
$48,000 | — | 31 Dec 2020 | |
| VALLEY NATIONAL ADVISERS INC |
13F
|
Company |
0.01%
|
2,000
|
$34,000 | — | 31 Dec 2020 | |
| Capital Asset Advisory Services LLC |
13F
|
Company |
0.01%
|
1,875
|
$32,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,700
|
$29,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,567
|
$27,000 | — | 31 Dec 2020 | |
| Covington Capital Management |
13F
|
Company |
0%
|
1,000
|
$17,000 | — | 31 Dec 2020 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
814
|
$14,000 | — | 31 Dec 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
800
|
$13,776 | — | 31 Dec 2020 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
700
|
$12,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
250
|
$4,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
40
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q1 2021
As of 31 Mar 2021,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,305,763 shares.
The largest 10 holders included
VANGUARD GROUP INC, Ikarian Capital, LLC, BlackRock Inc., DEUTSCHE BANK AG\, ROYAL BANK OF CANADA, GEODE CAPITAL MANAGEMENT, LLC, BANK OF MONTREAL /CAN/, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
25
Q1 2021 holders
32
Holder diff
7
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.